Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Heimburger

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
BMC Nephrology|February 20, 2019
Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patientsZhimin Chen, Abdul Rashid Qureshi, Torkel B Brismar, et al.
Nephron|September 26, 2018
Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot StudyAnna Levin, Deepika Nair, Abdul Rashid Qureshi, et al.
Journal of Clinical Medicine|November 13, 2025
Pentosidine and Bone Properties in Autosomal Dominant Polycystic Kidney DiseaseMagdalena Jankowska, Abdul Rashid Qureshi, Mathias Haarhaus, et al.
Plos One|October 5, 2016
Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney DiseaseAnna Machowska, Jia Sun, Abdul Rashid Qureshi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patientsPeter Stenvinkel, Ernesto Rodríguez-Ayala, Ziad A Massy, et al.
Nephron. Experimental Nephrology|July 5, 2008
The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutionsQiang Yao, Krzysztof Pawlaczyk, Ernesto Rodríguez Ayala, et al.
Bone|August 14, 2016
Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patientsZhimin Chen, Abdul Rashid Qureshi, Jonaz Ripsweden, et al.
Blood Purification|November 25, 2006
Peroxisome proliferator-activated receptor-gamma agonists diminish peritoneal functional and morphological changes induced by bioincompatible peritoneal dialysis solutionQiang Yao, Krzysztof Pawlaczyk, Ernesto Rodríguez Ayala, et al.
Blood Purification|December 5, 2008
Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patientsMichal Chmielewski, Peter Stenvinkel, Karin Luttropp, et al.
Molecular Medicine (Cambridge, Mass.)|December 17, 2008
Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activationAnnette Bruchfeld, Juan J Carrero, Abdul R Qureshi, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
BMC Nephrology|February 20, 2019
Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patientsZhimin Chen, Abdul Rashid Qureshi, Torkel B Brismar, et al.
Nephron|September 26, 2018
Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot StudyAnna Levin, Deepika Nair, Abdul Rashid Qureshi, et al.
Journal of Clinical Medicine|November 13, 2025
Pentosidine and Bone Properties in Autosomal Dominant Polycystic Kidney DiseaseMagdalena Jankowska, Abdul Rashid Qureshi, Mathias Haarhaus, et al.
Plos One|October 5, 2016
Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney DiseaseAnna Machowska, Jia Sun, Abdul Rashid Qureshi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patientsPeter Stenvinkel, Ernesto Rodríguez-Ayala, Ziad A Massy, et al.
Nephron. Experimental Nephrology|July 5, 2008
The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutionsQiang Yao, Krzysztof Pawlaczyk, Ernesto Rodríguez Ayala, et al.
Bone|August 14, 2016
Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patientsZhimin Chen, Abdul Rashid Qureshi, Jonaz Ripsweden, et al.
Blood Purification|November 25, 2006
Peroxisome proliferator-activated receptor-gamma agonists diminish peritoneal functional and morphological changes induced by bioincompatible peritoneal dialysis solutionQiang Yao, Krzysztof Pawlaczyk, Ernesto Rodríguez Ayala, et al.
Blood Purification|December 5, 2008
Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patientsMichal Chmielewski, Peter Stenvinkel, Karin Luttropp, et al.
Molecular Medicine (Cambridge, Mass.)|December 17, 2008
Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activationAnnette Bruchfeld, Juan J Carrero, Abdul R Qureshi, et al.
Pageof 6